SK695A3 - Heterocyclic compounds method of their production and using - Google Patents
Heterocyclic compounds method of their production and usingInfo
- Publication number
- SK695A3 SK695A3 SK6-95A SK695A SK695A3 SK 695 A3 SK695 A3 SK 695A3 SK 695 A SK695 A SK 695A SK 695 A3 SK695 A3 SK 695A3
- Authority
- SK
- Slovakia
- Prior art keywords
- group
- substituted
- compound
- alkyl
- aryl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
- C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
A compound of formula (I): <CHEM> or a tautomeric form thereof and/or a pharmaceutically acceptable salt thereof, and/or a pharmaceutically acceptable solvate thereof, wherein: A<1> represents a substituted or unsubstituted aromatic heterocyclyl group; A<2> represents a benzene ring having three optional substituents; A<3> represents a moiety of formula -(CH2)m-CH(OR<1>)- wherein R<1> represents substituted or unsubstituted alkyl, aryl, aralkyl or alkylcarbonyl and m represents an integer in the range of from 1 to 5, or A<3> represents a moiety of formula - (CH2)m-1-CH=C(OR<1>)- wherein R<1> and m are as defined above; R<2> represents OR<3> wherein R<3> represents hydrogen, alkyl, aryl or aralkyl or R<2> represents an aromatic heterocyclyl group or -NR<4>R<5> wherein R<4> and R<5> each independently represent hydrogen, alkyl or alkylcarbonyl or R<4> and R<5> together with the nitrogen atom to which they are attached form a heterocyclic ring, providing that R<2> represents an aromatic heterocyclyl group only when Y as defined below represents a bond ; X represents NR wherein R represents a hydrogen atom, an alkyl group, an acyl group, an aralkyl group wherein the aryl moiety may be substituted or unsubstituted, or a substituted or unsubstituted aryl group; Y represents CO or CS or a bond providing that Y represents a bond only when R<2> represents the above mentioned aromatic heterocyclyl group; and n represents an integer in the range of from 2 to 6; a process for preparing such a compound, a composition comprising such a compound and the use of such a compound and composition in medicine.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB929214185A GB9214185D0 (en) | 1992-07-03 | 1992-07-03 | Novel compounds |
GB929227030A GB9227030D0 (en) | 1992-12-29 | 1992-12-29 | Novel compounds |
GB939311027A GB9311027D0 (en) | 1993-05-28 | 1993-05-28 | Novel compounds |
PCT/GB1993/001363 WO1994001420A1 (en) | 1992-07-03 | 1993-06-29 | Heterocyclic compounds as pharmaceutical |
Publications (1)
Publication Number | Publication Date |
---|---|
SK695A3 true SK695A3 (en) | 1995-07-11 |
Family
ID=27266276
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SK6-95A SK695A3 (en) | 1992-07-03 | 1993-06-29 | Heterocyclic compounds method of their production and using |
Country Status (19)
Country | Link |
---|---|
US (2) | US6048883A (en) |
EP (2) | EP0648212B1 (en) |
JP (1) | JPH07508747A (en) |
KR (1) | KR950702545A (en) |
CN (2) | CN1042532C (en) |
AT (1) | ATE207470T1 (en) |
AU (1) | AU678974B2 (en) |
CA (1) | CA2139442A1 (en) |
CZ (1) | CZ1095A3 (en) |
DE (1) | DE69331010D1 (en) |
FI (1) | FI950016A (en) |
HU (1) | HUT71247A (en) |
MX (1) | MX9303981A (en) |
NO (2) | NO305318B1 (en) |
NZ (1) | NZ253742A (en) |
PL (2) | PL176885B1 (en) |
RU (1) | RU2134686C1 (en) |
SK (1) | SK695A3 (en) |
WO (1) | WO1994001420A1 (en) |
Families Citing this family (74)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9311644D0 (en) * | 1993-06-05 | 1993-07-21 | Smithkline Beecham Plc | Novel compounds |
GB9311661D0 (en) * | 1993-06-05 | 1993-07-21 | Smithkline Beecham Plc | Novel compounds |
GB9315148D0 (en) * | 1993-07-22 | 1993-09-08 | Smithkline Beecham Plc | Novel compounds |
GB9326171D0 (en) * | 1993-12-22 | 1994-02-23 | Smithkline Beecham Plc | Novel compounds |
JPH10503508A (en) * | 1994-07-29 | 1998-03-31 | スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー | Benzoxazole and pyridine derivatives useful in the treatment of type II diabetes |
WO1996004261A1 (en) * | 1994-07-29 | 1996-02-15 | Smithkline Beecham Plc | Benzoxazoles and pryridine derivatives useful in the treatment of the type ii diabetes |
GB9600464D0 (en) * | 1996-01-09 | 1996-03-13 | Smithkline Beecham Plc | Novel method |
US6090836A (en) * | 1996-02-02 | 2000-07-18 | Merck & Co., Inc. | Benzisoxazole-derived antidiabetic compounds |
US6020382A (en) * | 1996-02-02 | 2000-02-01 | Merck & Co., Inc. | Method of treating diabetes and related disease states |
US5859051A (en) * | 1996-02-02 | 1999-01-12 | Merck & Co., Inc. | Antidiabetic agents |
US5847008A (en) * | 1996-02-02 | 1998-12-08 | Merck & Co., Inc. | Method of treating diabetes and related disease states |
GB9604242D0 (en) | 1996-02-28 | 1996-05-01 | Glaxo Wellcome Inc | Chemical compounds |
US6160000A (en) * | 1996-12-23 | 2000-12-12 | Merck & Co., Inc. | Antidiabetic agents based on aryl and heteroarylacetic acids |
US6090839A (en) * | 1996-12-23 | 2000-07-18 | Merck & Co., Inc. | Antidiabetic agents |
CN1168451C (en) | 1997-06-18 | 2004-09-29 | 史密丝克莱恩比彻姆有限公司 | Treatment of diabetes with thiazolidinedione and sulphonylurea |
WO1999019313A1 (en) * | 1997-10-27 | 1999-04-22 | Dr. Reddy's Research Foundation | Novel tricyclic compounds and their use in medicine; process for their preparation and pharmaceutical compositions containing them |
MXPA00004036A (en) | 1997-10-27 | 2006-05-24 | Reddys Lab Ltd Dr | Novel tricyclic compounds and their use in medicine; process for their preparation and pharmaceutical compositions containing them. |
CA2307068C (en) | 1997-10-27 | 2007-04-10 | Dr. Reddy's Research Foundation | Bicyclic compounds, process for their preparation and pharmaceutical compositions containing them |
US6440961B1 (en) | 1997-10-27 | 2002-08-27 | Dr. Reddy's Research Foundation | Tricyclic compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them |
US6369067B1 (en) | 1997-10-27 | 2002-04-09 | Dr. Reddy's Research Foundation | Monocyclic compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them |
US6444816B1 (en) | 1997-10-27 | 2002-09-03 | Dr. Reddy's Research Foundation | Fused 7-oxo-pyrimidinyl compounds, preparation, composition and use thereof |
CN1280574A (en) * | 1997-10-27 | 2001-01-17 | 雷迪研究基金会 | New heterocyclic compounds and their use in medicine, process for their prepartion and pharmaceutical compositions containing them |
US6265401B1 (en) | 1997-10-27 | 2001-07-24 | Reddy-Cheminor, Inc. | Bicyclic compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them |
GB2380997B (en) * | 1997-10-27 | 2003-07-02 | Reddys Lab Ltd Dr | Novel aryl-oxysubstituted alkyl carboxylic acids; process for their preparation and pharmaceutical compositions containing them |
CN1208326C (en) * | 1998-04-23 | 2005-06-29 | 雷迪实验室有限公司 | New heterocyclic compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them |
SE9801992D0 (en) * | 1998-06-04 | 1998-06-04 | Astra Ab | New 3-aryl-2-hydroxypropionic acid derivative I |
DZ2937A1 (en) | 1998-11-12 | 2004-03-15 | Smithkline Beecham Plc | New compositions of insulin sensitizers. |
WO2000028989A1 (en) | 1998-11-12 | 2000-05-25 | Smithkline Beecham P.L.C. | Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent |
US7000106B2 (en) * | 1999-03-26 | 2006-02-14 | Siemens Communications, Inc. | Methods and apparatus for kernel mode encryption of computer telephony |
US6972294B1 (en) | 1999-04-20 | 2005-12-06 | Novo Nordisk, A/S | Compounds, their preparation and use |
CA2382966A1 (en) | 1999-08-27 | 2001-03-08 | Eli Lilly And Company | Biaryl-oxa(thia)zole derivatives and their use as ppars modulators |
SE9904415D0 (en) * | 1999-12-03 | 1999-12-03 | Astra Ab | New process |
HU230609B1 (en) * | 2000-01-19 | 2017-03-28 | Cadila Healthcare Ltd. | Compounds having hypolipidemic and hypocholesterolemic activities, process for their preparation and pharmaceutical compositions containing them and their use, intermediates |
WO2001055086A1 (en) * | 2000-01-28 | 2001-08-02 | Novo Nordisk A/S | Alkynylsubstituted propionic acid derivatives and their use against diabetes and obesity |
US6555577B1 (en) | 2000-01-28 | 2003-04-29 | Novo Nordisk A/S | Compounds, their preparation and use |
US6569901B2 (en) | 2000-01-28 | 2003-05-27 | Novo Nordisk A/S | Alkynyl-substituted propionic acid derivatives, their preparation and use |
US6509374B2 (en) | 2000-04-17 | 2003-01-21 | Novo Nordisk A/S | Compounds, their preparation and use |
GB0014969D0 (en) | 2000-06-19 | 2000-08-09 | Smithkline Beecham Plc | Novel method of treatment |
US6559335B2 (en) | 2000-09-22 | 2003-05-06 | Dr. Reddy's Laboratories Limited | Process for the preparation of 3-aryl-2-hydroxy propanoic acid |
TWI311133B (en) * | 2001-04-20 | 2009-06-21 | Eisai R&D Man Co Ltd | Carboxylic acid derivativeand the salt thereof |
IL158589A0 (en) | 2001-05-15 | 2004-05-12 | Hoffmann La Roche | Carboxylic acid substituted oxazole derivatives for use as ppar-alpha and -gamma activators in the treatment of diabetes |
US6987123B2 (en) * | 2001-07-26 | 2006-01-17 | Cadila Healthcare Limited | Heterocyclic compounds, their preparation, pharmaceutical compositions containing them and their use in medicine |
US7067530B2 (en) | 2001-07-30 | 2006-06-27 | Novo Nordisk A/S | Compounds, their preparation and use |
US6869967B2 (en) | 2001-07-30 | 2005-03-22 | Novo Nordisk A/S | Peroxisome proliferator-activated receptor (PPAR) active vinyl carboxylic acid derivatives |
JPWO2003016265A1 (en) | 2001-08-17 | 2004-12-02 | エーザイ株式会社 | Cyclic compounds and PPAR agonists |
US7220877B2 (en) | 2001-10-17 | 2007-05-22 | Novo Nordisk A/S | Compounds, their preparation and use |
JP2005518408A (en) | 2001-12-29 | 2005-06-23 | ノボ ノルディスク アクティーゼルスカブ | Combination use of GLP-1 compounds and other drugs to treat dyslipidemia |
US8268352B2 (en) * | 2002-08-05 | 2012-09-18 | Torrent Pharmaceuticals Limited | Modified release composition for highly soluble drugs |
US8216609B2 (en) * | 2002-08-05 | 2012-07-10 | Torrent Pharmaceuticals Limited | Modified release composition of highly soluble drugs |
US7232828B2 (en) | 2002-08-10 | 2007-06-19 | Bethesda Pharmaceuticals, Inc. | PPAR Ligands that do not cause fluid retention, edema or congestive heart failure |
PT1537091E (en) | 2002-08-30 | 2010-11-11 | Hoffmann La Roche | Novel 2-arylthiazole compounds as pparalpha and ppargamma agonists |
CN100577660C (en) | 2002-09-12 | 2010-01-06 | 霍夫曼-拉罗奇有限公司 | N-substituted-1H-indol-5-propionic acid compounds as PPAR agonists used for the treatment of diabetes |
WO2004048371A1 (en) | 2002-11-25 | 2004-06-10 | F.Hoffmann-La Roche Ag | Indolyl derivatives |
US7816385B2 (en) | 2002-12-20 | 2010-10-19 | High Point Pharmaceuticals, Llc | Dimeric dicarboxylic acid derivatives, their preparation and use |
US6653334B1 (en) | 2002-12-27 | 2003-11-25 | Kowa Co., Ltd. | Benzoxazole compound and pharmaceutical composition containing the same |
US20050182125A1 (en) * | 2003-05-16 | 2005-08-18 | Ambit Biosciences Corporation | Pyrrole compounds and uses thereof |
US20040248972A1 (en) * | 2003-05-16 | 2004-12-09 | Ambit Biosciences Corporation | Compounds and uses thereof |
CA2523808A1 (en) * | 2003-05-16 | 2004-12-23 | Ambit Biosciences Corporation | Pyrrole compounds and uses thereof |
PE20061099A1 (en) * | 2005-02-25 | 2006-12-05 | Takeda Pharmaceutical | PYRIDYL ACETIC ACID COMPOUNDS AS PEPTIDASE INHIBITORS |
WO2008117982A1 (en) * | 2007-03-28 | 2008-10-02 | Crystal Genomics, Inc. | Heterocyclic carboxylic acid derivatives and pharmaceutical composition for inhibiting lipid accumulation containing same |
EP2154131A4 (en) * | 2007-04-26 | 2011-09-21 | Pharmafrontier Co Ltd | G protein-coupled receptor inhibitor and pharmaceutical product |
WO2012104869A1 (en) | 2011-01-31 | 2012-08-09 | Cadila Healthcare Limited | Treatment for lipodystrophy |
KR101617812B1 (en) | 2013-04-22 | 2016-05-03 | 카딜라 핼쓰캐어 리미티드 | A novel composition for nonalcoholic fatty liver disease |
US20160107989A1 (en) | 2013-05-30 | 2016-04-21 | Cadila Healthcare Limited | A process for preparation of pyrroles having hypolipidemic hypocholesteremic activities |
TW201513857A (en) | 2013-07-05 | 2015-04-16 | Cadila Healthcare Ltd | Synergistic compositions |
IN2013MU02470A (en) | 2013-07-25 | 2015-06-26 | Cadila Healthcare Ltd | |
CN103467409B (en) * | 2013-09-03 | 2015-01-07 | 浙江医药高等专科学校 | Substituted tetrazole carboxylic acid compounds and application thereof |
CN103467405B (en) * | 2013-09-03 | 2015-01-07 | 浙江医药高等专科学校 | Tetrazole carboxylic acid compounds, and preparation method and application thereof |
CN103467408B (en) * | 2013-09-03 | 2015-01-21 | 浙江医药高等专科学校 | Tetrazole carboxylic acid compounds and application thereof |
CN103467407B (en) * | 2013-09-03 | 2015-04-22 | 浙江医药高等专科学校 | Tetrazole carboxylic acid compounds and application thereof |
CN103467406B (en) * | 2013-09-03 | 2014-12-17 | 浙江医药高等专科学校 | Halogen-substituted tetrazole carboxylic acid compounds, and preparation method and application thereof |
US10112898B2 (en) | 2013-09-06 | 2018-10-30 | Cadila Healthcare Limited | Process for the preparation of saroglitazar pharmaceutical salts |
WO2017064635A2 (en) | 2015-10-14 | 2017-04-20 | Cadila Healthcare Limited | Pyrrole compound, compositions and process for preparation thereof |
JP6840853B2 (en) | 2016-12-09 | 2021-03-10 | カディラ・ヘルスケア・リミテッド | Treatment of primary biliary cholangitis |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0306228B1 (en) * | 1987-09-04 | 1999-11-17 | Beecham Group Plc | Substituted thiazolidinedione derivatives |
US5232925A (en) * | 1987-09-04 | 1993-08-03 | Beecham Group P.L.C. | Compounds |
US5194443A (en) * | 1987-09-04 | 1993-03-16 | Beecham Group P.L.C. | Compounds |
US5089514A (en) * | 1990-06-14 | 1992-02-18 | Pfizer Inc. | 3-coxazolyl [phenyl, chromanyl or benzofuranyl]-2-hydroxypropionic acid derivatives and analogs as hypoglycemic agents |
GB9017218D0 (en) * | 1990-08-06 | 1990-09-19 | Beecham Group Plc | Novel compounds |
-
1993
- 1993-06-29 SK SK6-95A patent/SK695A3/en unknown
- 1993-06-29 EP EP93914841A patent/EP0648212B1/en not_active Expired - Lifetime
- 1993-06-29 JP JP6503071A patent/JPH07508747A/en active Pending
- 1993-06-29 EP EP99204395A patent/EP1000938A1/en not_active Withdrawn
- 1993-06-29 AT AT93914841T patent/ATE207470T1/en not_active IP Right Cessation
- 1993-06-29 CZ CZ9510A patent/CZ1095A3/en unknown
- 1993-06-29 AU AU45068/93A patent/AU678974B2/en not_active Ceased
- 1993-06-29 RU RU94046169A patent/RU2134686C1/en active
- 1993-06-29 NZ NZ253742A patent/NZ253742A/en unknown
- 1993-06-29 US US08/360,755 patent/US6048883A/en not_active Expired - Fee Related
- 1993-06-29 WO PCT/GB1993/001363 patent/WO1994001420A1/en not_active Application Discontinuation
- 1993-06-29 CA CA002139442A patent/CA2139442A1/en not_active Abandoned
- 1993-06-29 PL PL93316129A patent/PL176885B1/en unknown
- 1993-06-29 PL PL93307087A patent/PL174610B1/en unknown
- 1993-06-29 DE DE69331010T patent/DE69331010D1/en not_active Expired - Lifetime
- 1993-06-29 KR KR1019940704886A patent/KR950702545A/en not_active Application Discontinuation
- 1993-06-29 HU HU9500006A patent/HUT71247A/en unknown
- 1993-07-01 MX MX9303981A patent/MX9303981A/en not_active IP Right Cessation
- 1993-07-02 CN CN93109874A patent/CN1042532C/en not_active Expired - Fee Related
-
1995
- 1995-01-02 NO NO950009A patent/NO305318B1/en not_active IP Right Cessation
- 1995-01-02 FI FI950016A patent/FI950016A/en unknown
- 1995-06-02 US US08/458,335 patent/US5869495A/en not_active Expired - Fee Related
-
1998
- 1998-05-14 CN CN98108909A patent/CN1215724A/en active Pending
-
1999
- 1999-01-19 NO NO990227A patent/NO990227D0/en unknown
Also Published As
Publication number | Publication date |
---|---|
NO990227L (en) | 1995-03-02 |
RU2134686C1 (en) | 1999-08-20 |
MX9303981A (en) | 1994-04-29 |
CN1095716A (en) | 1994-11-30 |
NO950009D0 (en) | 1995-01-02 |
US5869495A (en) | 1999-02-09 |
CN1042532C (en) | 1999-03-17 |
EP0648212B1 (en) | 2001-10-24 |
HUT71247A (en) | 1995-11-28 |
EP1000938A1 (en) | 2000-05-17 |
CA2139442A1 (en) | 1994-01-20 |
WO1994001420A1 (en) | 1994-01-20 |
KR950702545A (en) | 1995-07-29 |
FI950016A0 (en) | 1995-01-02 |
NO950009L (en) | 1995-03-02 |
NO305318B1 (en) | 1999-05-10 |
CN1215724A (en) | 1999-05-05 |
NO990227D0 (en) | 1999-01-19 |
US6048883A (en) | 2000-04-11 |
HU9500006D0 (en) | 1995-03-28 |
AU678974B2 (en) | 1997-06-19 |
RU94046169A (en) | 1996-10-27 |
PL307087A1 (en) | 1995-05-02 |
PL174610B1 (en) | 1998-08-31 |
EP0648212A1 (en) | 1995-04-19 |
DE69331010D1 (en) | 2001-11-29 |
ATE207470T1 (en) | 2001-11-15 |
FI950016A (en) | 1995-03-02 |
AU4506893A (en) | 1994-01-31 |
PL176885B1 (en) | 1999-08-31 |
NZ253742A (en) | 1997-06-24 |
JPH07508747A (en) | 1995-09-28 |
CZ1095A3 (en) | 1995-10-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SK695A3 (en) | Heterocyclic compounds method of their production and using | |
PT88410A (en) | PROCESS FOR PREPARING THIAZOLIDINEDIONE DERIVATIVES | |
GB8919434D0 (en) | Novel compounds | |
GB8919417D0 (en) | Novel compounds | |
EP0356214A3 (en) | Thiazolidine dione derivatives | |
GB9308487D0 (en) | Novel compounds | |
NZ229347A (en) | Substituted cephalosporin derivatives; pharmaceutical compositions, preparatory processes and intermediates | |
DE69625795D1 (en) | Thiazolidinedione derivatives with antidiabetic, hypolipidemic and antihypertensive properties, processes for their preparation and pharmaceutical compositions containing them | |
UA50722C2 (en) | Nitrobenzamides, method for their production (variants), pharmaceutical composition | |
MX15697A (en) | HETEROTETRACICLIC DERIVATIVES OF LACTAMA AND PROCESS FOR ITS PREPARATION | |
NZ240272A (en) | Piperazine derivatives; pharmaceutical compositions and preparatory processes |